Rethinking Polycythemia Vera and Myeloproliferative Neoplasms: The Case for Combination Therapy, Drug Repurposing, and Lifestyle Integration
Executive Overview Polycythemia Vera (PV) and related Philadelphia-negative myeloproliferative neoplasms (MPNs)—such as essential thrombocythemia (ET) and myelofibrosis (MF)—represent a complex spectrum of chronic blood cancers. Driven primarily by somatic mutations…